Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fatty Acids, Volatile | 2 | 2023 | 100 | 0.910 |
Why?
|
Niacin | 1 | 2023 | 119 | 0.850 |
Why?
|
Prediabetic State | 2 | 2023 | 546 | 0.740 |
Why?
|
Plaque, Atherosclerotic | 1 | 2022 | 1517 | 0.360 |
Why?
|
Bacteria | 1 | 2021 | 2188 | 0.340 |
Why?
|
Atherosclerosis | 1 | 2022 | 3525 | 0.260 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15728 | 0.250 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 412 | 0.250 |
Why?
|
Diet | 3 | 2024 | 8002 | 0.240 |
Why?
|
Feces | 4 | 2024 | 1462 | 0.240 |
Why?
|
Retinoids | 1 | 2024 | 99 | 0.230 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12268 | 0.210 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11888 | 0.200 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2016 | 750 | 0.200 |
Why?
|
Vitamin A | 1 | 2024 | 613 | 0.190 |
Why?
|
Carotenoids | 1 | 2024 | 620 | 0.190 |
Why?
|
Bile Acids and Salts | 1 | 2023 | 380 | 0.180 |
Why?
|
Glycemic Index | 1 | 2021 | 395 | 0.160 |
Why?
|
Hyperlipidemias | 1 | 2023 | 782 | 0.150 |
Why?
|
Fasting | 1 | 2023 | 1603 | 0.140 |
Why?
|
Chemokine CCL1 | 1 | 2016 | 20 | 0.140 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4286 | 0.140 |
Why?
|
Interleukin-11 | 1 | 2016 | 59 | 0.140 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 732 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 830 | 0.120 |
Why?
|
Metabolomics | 1 | 2023 | 1620 | 0.120 |
Why?
|
Bariatric Surgery | 1 | 2023 | 993 | 0.110 |
Why?
|
Blood Glucose | 2 | 2023 | 6368 | 0.100 |
Why?
|
Glucose | 1 | 2023 | 4361 | 0.100 |
Why?
|
Hypertension | 2 | 2021 | 8594 | 0.090 |
Why?
|
Portugal | 2 | 2008 | 90 | 0.090 |
Why?
|
Energy Metabolism | 1 | 2021 | 2869 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6311 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2021 | 3959 | 0.070 |
Why?
|
Humans | 17 | 2024 | 759255 | 0.070 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2007 | 113 | 0.070 |
Why?
|
MicroRNAs | 2 | 2014 | 3797 | 0.070 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2007 | 760 | 0.070 |
Why?
|
Risk Factors | 3 | 2023 | 74167 | 0.070 |
Why?
|
Inflammation | 2 | 2023 | 10747 | 0.070 |
Why?
|
Lung Neoplasms | 3 | 2016 | 13238 | 0.060 |
Why?
|
Polymerase Chain Reaction | 3 | 2014 | 6070 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11324 | 0.060 |
Why?
|
DNA | 2 | 2008 | 7237 | 0.060 |
Why?
|
Lung Diseases, Interstitial | 1 | 2012 | 898 | 0.050 |
Why?
|
DNA, Neoplasm | 1 | 2008 | 1744 | 0.050 |
Why?
|
Appetite | 1 | 2023 | 247 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9374 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1790 | 0.040 |
Why?
|
Aged | 5 | 2024 | 168617 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12896 | 0.040 |
Why?
|
Prostate | 1 | 2007 | 1781 | 0.040 |
Why?
|
Blood Proteins | 1 | 2023 | 1163 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8491 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1003 | 0.040 |
Why?
|
Polysaccharides | 1 | 2023 | 1011 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2021 | 2058 | 0.030 |
Why?
|
Adult | 4 | 2024 | 219390 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5247 | 0.030 |
Why?
|
Triglycerides | 1 | 2023 | 2475 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2012 | 21988 | 0.030 |
Why?
|
Genotype | 1 | 2007 | 12940 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 522 | 0.020 |
Why?
|
Middle Aged | 6 | 2024 | 219653 | 0.020 |
Why?
|
Homeostasis | 1 | 2021 | 3304 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1532 | 0.020 |
Why?
|
Female | 8 | 2024 | 390240 | 0.020 |
Why?
|
Insulin | 1 | 2023 | 6591 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3930 | 0.020 |
Why?
|
Prognosis | 1 | 2007 | 29561 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8523 | 0.020 |
Why?
|
Male | 5 | 2024 | 358719 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15641 | 0.020 |
Why?
|
Body Mass Index | 1 | 2021 | 12874 | 0.010 |
Why?
|
Reference Values | 1 | 2008 | 4918 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4412 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2008 | 21022 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25860 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7595 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4025 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54204 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58483 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64879 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15264 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 41247 | 0.010 |
Why?
|
Animals | 1 | 2021 | 167838 | 0.010 |
Why?
|
Concepts
(86)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_